These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 19387126
1. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology. Sharpless KE, O'Sullivan DM, Schnatz PF. J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126 [Abstract] [Full Text] [Related]
2. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells. Saqi A, Gupta PK, Erroll M, Babiac A, Blackmun D, Mansukhani M, Vazquez M. Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857 [Abstract] [Full Text] [Related]
4. Use of human papillomavirus testing in the management of atypical glandular cells. Schnatz PF, Sharpless KE, O'Sullivan DM. J Low Genit Tract Dis; 2009 Apr; 13(2):94-101. PubMed ID: 19387129 [Abstract] [Full Text] [Related]
5. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C. Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515 [Abstract] [Full Text] [Related]
6. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing. Johnston EI, Logani S. Cancer; 2007 Jun 25; 111(3):160-5. PubMed ID: 17506090 [Abstract] [Full Text] [Related]
9. Impact of reflex HPV testing on interpretation and management of ThinPrep Pap tests. Peng Y, Wang HH. Diagn Cytopathol; 2006 Aug 25; 34(8):585-8. PubMed ID: 16850488 [Abstract] [Full Text] [Related]
10. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results. Cox JT. J Clin Virol; 2009 Jul 25; 45 Suppl 1():S3-S12. PubMed ID: 19651367 [Abstract] [Full Text] [Related]
15. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis. Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC. Cytopathology; 2009 Aug 25; 20(4):249-55. PubMed ID: 19018810 [Abstract] [Full Text] [Related]
16. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance. Fletcher AH, Wilkinson EJ, Knapik JA. J Low Genit Tract Dis; 2009 Jan 25; 13(1):28-32. PubMed ID: 19098603 [Abstract] [Full Text] [Related]
17. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. Coutlée F, Trottier H, Gagnon S, Koushik A, Richardson H, Roger M, Ferenczy AS, Franco EL. J Clin Virol; 2009 Jun 25; 45(2):96-9. PubMed ID: 19398216 [Abstract] [Full Text] [Related]
18. [Detection of multiple human papillomavirus infection in cervical specimens by flow fluorescent hybridization]. Chen QY, Bian ML, Zhang XY, Ou H, Ma L. Zhonghua Yi Xue Za Zhi; 2009 Apr 07; 89(13):901-5. PubMed ID: 19671291 [Abstract] [Full Text] [Related]
19. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Dehn D, Torkko KC, Shroyer KR. Cancer; 2007 Feb 25; 111(1):1-14. PubMed ID: 17219448 [Abstract] [Full Text] [Related]
20. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening. Papa D, Moore Simas TA, Reynolds M, Melnitsky H. J Low Genit Tract Dis; 2009 Apr 25; 13(2):66-71. PubMed ID: 19387125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]